Global Meningococcal Conjugate Supply, Demand and Key Producers, 2023-2029

Description

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

This report studies the global Meningococcal Conjugate demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Meningococcal Conjugate, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meningococcal Conjugate that contribute to its increasing demand across many markets.

The global Meningococcal Conjugate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Meningococcal Conjugate total market, 2018-2029, (USD Million)
Global Meningococcal Conjugate total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Meningococcal Conjugate total market, key domestic companies and share, (USD Million)
Global Meningococcal Conjugate revenue by player and market share 2018-2023, (USD Million)
Global Meningococcal Conjugate total market by Type, CAGR, 2018-2029, (USD Million)
Global Meningococcal Conjugate total market by End User, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Meningococcal Conjugate market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meningococcal Conjugate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Meningococcal Conjugate Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Meningococcal Conjugate Market, Segmentation by Type
    Menactra
    Menveo
    NeisVac-C
    Nimenrix
    Others

Global Meningococcal Conjugate Market, Segmentation by End User
    Children
    Preteens or Teens
    Adults

Companies Profiled:
    Sanofi Pasteur
    Pfizer
    Glaxo Smith Kline
    Hualan Biological Engineering
    JN International Medical Corporation
    Baxter International
    Merck
    Serum Institute of India
    Biomed
    Novartis

Key Questions Answered
1. How big is the global Meningococcal Conjugate market?
2. What is the demand of the global Meningococcal Conjugate market?
3. What is the year over year growth of the global Meningococcal Conjugate market?
4. What is the total value of the global Meningococcal Conjugate market?
5. Who are the major players in the global Meningococcal Conjugate market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Meningococcal Conjugate Introduction
    1.2 World Meningococcal Conjugate Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Meningococcal Conjugate Total Market by Region (by Headquarter Location)
        1.3.1 World Meningococcal Conjugate Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Meningococcal Conjugate Market Size (2018-2029)
        1.3.3 China Meningococcal Conjugate Market Size (2018-2029)
        1.3.4 Europe Meningococcal Conjugate Market Size (2018-2029)
        1.3.5 Japan Meningococcal Conjugate Market Size (2018-2029)
        1.3.6 South Korea Meningococcal Conjugate Market Size (2018-2029)
        1.3.7 ASEAN Meningococcal Conjugate Market Size (2018-2029)
        1.3.8 India Meningococcal Conjugate Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Meningococcal Conjugate Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Meningococcal Conjugate Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Meningococcal Conjugate Consumption Value (2018-2029)
    2.2 World Meningococcal Conjugate Consumption Value by Region
        2.2.1 World Meningococcal Conjugate Consumption Value by Region (2018-2023)
        2.2.2 World Meningococcal Conjugate Consumption Value Forecast by Region (2024-2029)
    2.3 United States Meningococcal Conjugate Consumption Value (2018-2029)
    2.4 China Meningococcal Conjugate Consumption Value (2018-2029)
    2.5 Europe Meningococcal Conjugate Consumption Value (2018-2029)
    2.6 Japan Meningococcal Conjugate Consumption Value (2018-2029)
    2.7 South Korea Meningococcal Conjugate Consumption Value (2018-2029)
    2.8 ASEAN Meningococcal Conjugate Consumption Value (2018-2029)
    2.9 India Meningococcal Conjugate Consumption Value (2018-2029)

3 World Meningococcal Conjugate Companies Competitive Analysis
    3.1 World Meningococcal Conjugate Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Meningococcal Conjugate Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Meningococcal Conjugate in 2022
        3.2.3 Global Concentration Ratios (CR8) for Meningococcal Conjugate in 2022
    3.3 Meningococcal Conjugate Company Evaluation Quadrant
    3.4 Meningococcal Conjugate Market: Overall Company Footprint Analysis
        3.4.1 Meningococcal Conjugate Market: Region Footprint
        3.4.2 Meningococcal Conjugate Market: Company Product Type Footprint
        3.4.3 Meningococcal Conjugate Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Meningococcal Conjugate Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Meningococcal Conjugate Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Meningococcal Conjugate Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Meningococcal Conjugate Consumption Value Comparison
        4.2.1 United States VS China: Meningococcal Conjugate Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Meningococcal Conjugate Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Meningococcal Conjugate Companies and Market Share, 2018-2023
        4.3.1 United States Based Meningococcal Conjugate Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Meningococcal Conjugate Revenue, (2018-2023)
    4.4 China Based Companies Meningococcal Conjugate Revenue and Market Share, 2018-2023
        4.4.1 China Based Meningococcal Conjugate Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Meningococcal Conjugate Revenue, (2018-2023)
    4.5 Rest of World Based Meningococcal Conjugate Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Meningococcal Conjugate Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Meningococcal Conjugate Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Meningococcal Conjugate Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Menactra
        5.2.2 Menveo
        5.2.3 NeisVac-C
        5.2.4 Nimenrix
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Meningococcal Conjugate Market Size by Type (2018-2023)
        5.3.2 World Meningococcal Conjugate Market Size by Type (2024-2029)
        5.3.3 World Meningococcal Conjugate Market Size Market Share by Type (2018-2029)

6 Market Analysis by End User
    6.1 World Meningococcal Conjugate Market Size Overview by End User: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by End User
        6.2.1 Children
        6.2.2 Preteens or Teens
        6.2.3 Adults
    6.3 Market Segment by End User
        6.3.1 World Meningococcal Conjugate Market Size by End User (2018-2023)
        6.3.2 World Meningococcal Conjugate Market Size by End User (2024-2029)
        6.3.3 World Meningococcal Conjugate Market Size by End User (2018-2029)

7 Company Profiles
    7.1 Sanofi Pasteur
        7.1.1 Sanofi Pasteur Details
        7.1.2 Sanofi Pasteur Major Business
        7.1.3 Sanofi Pasteur Meningococcal Conjugate Product and Services
        7.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Pasteur Recent Developments/Updates
        7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Meningococcal Conjugate Product and Services
        7.2.4 Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Glaxo Smith Kline
        7.3.1 Glaxo Smith Kline Details
        7.3.2 Glaxo Smith Kline Major Business
        7.3.3 Glaxo Smith Kline Meningococcal Conjugate Product and Services
        7.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Glaxo Smith Kline Recent Developments/Updates
        7.3.6 Glaxo Smith Kline Competitive Strengths & Weaknesses
    7.4 Hualan Biological Engineering
        7.4.1 Hualan Biological Engineering Details
        7.4.2 Hualan Biological Engineering Major Business
        7.4.3 Hualan Biological Engineering Meningococcal Conjugate Product and Services
        7.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Hualan Biological Engineering Recent Developments/Updates
        7.4.6 Hualan Biological Engineering Competitive Strengths & Weaknesses
    7.5 JN International Medical Corporation
        7.5.1 JN International Medical Corporation Details
        7.5.2 JN International Medical Corporation Major Business
        7.5.3 JN International Medical Corporation Meningococcal Conjugate Product and Services
        7.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 JN International Medical Corporation Recent Developments/Updates
        7.5.6 JN International Medical Corporation Competitive Strengths & Weaknesses
    7.6 Baxter International
        7.6.1 Baxter International Details
        7.6.2 Baxter International Major Business
        7.6.3 Baxter International Meningococcal Conjugate Product and Services
        7.6.4 Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Baxter International Recent Developments/Updates
        7.6.6 Baxter International Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Meningococcal Conjugate Product and Services
        7.7.4 Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 Serum Institute of India
        7.8.1 Serum Institute of India Details
        7.8.2 Serum Institute of India Major Business
        7.8.3 Serum Institute of India Meningococcal Conjugate Product and Services
        7.8.4 Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Serum Institute of India Recent Developments/Updates
        7.8.6 Serum Institute of India Competitive Strengths & Weaknesses
    7.9 Biomed
        7.9.1 Biomed Details
        7.9.2 Biomed Major Business
        7.9.3 Biomed Meningococcal Conjugate Product and Services
        7.9.4 Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Biomed Recent Developments/Updates
        7.9.6 Biomed Competitive Strengths & Weaknesses
    7.10 Novartis
        7.10.1 Novartis Details
        7.10.2 Novartis Major Business
        7.10.3 Novartis Meningococcal Conjugate Product and Services
        7.10.4 Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Novartis Recent Developments/Updates
        7.10.6 Novartis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Meningococcal Conjugate Industry Chain
    8.2 Meningococcal Conjugate Upstream Analysis
    8.3 Meningococcal Conjugate Midstream Analysis
    8.4 Meningococcal Conjugate Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Meningococcal Conjugate Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Meningococcal Conjugate Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Meningococcal Conjugate Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Meningococcal Conjugate Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Meningococcal Conjugate Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Meningococcal Conjugate Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Meningococcal Conjugate Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Meningococcal Conjugate Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Meningococcal Conjugate Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Meningococcal Conjugate Players in 2022
    Table 12. World Meningococcal Conjugate Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Meningococcal Conjugate Company Evaluation Quadrant
    Table 14. Head Office of Key Meningococcal Conjugate Player
    Table 15. Meningococcal Conjugate Market: Company Product Type Footprint
    Table 16. Meningococcal Conjugate Market: Company Product Application Footprint
    Table 17. Meningococcal Conjugate Mergers & Acquisitions Activity
    Table 18. United States VS China Meningococcal Conjugate Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Meningococcal Conjugate Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Meningococcal Conjugate Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Meningococcal Conjugate Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Meningococcal Conjugate Revenue Market Share (2018-2023)
    Table 23. China Based Meningococcal Conjugate Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Meningococcal Conjugate Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Meningococcal Conjugate Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Meningococcal Conjugate Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Meningococcal Conjugate Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Meningococcal Conjugate Revenue Market Share (2018-2023)
    Table 29. World Meningococcal Conjugate Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Meningococcal Conjugate Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Meningococcal Conjugate Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Meningococcal Conjugate Market Size by End User, (USD Million), 2018 & 2022 & 2029
    Table 33. World Meningococcal Conjugate Market Size by End User (2018-2023) & (USD Million)
    Table 34. World Meningococcal Conjugate Market Size by End User (2024-2029) & (USD Million)
    Table 35. Sanofi Pasteur Basic Information, Area Served and Competitors
    Table 36. Sanofi Pasteur Major Business
    Table 37. Sanofi Pasteur Meningococcal Conjugate Product and Services
    Table 38. Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Sanofi Pasteur Recent Developments/Updates
    Table 40. Sanofi Pasteur Competitive Strengths & Weaknesses
    Table 41. Pfizer Basic Information, Area Served and Competitors
    Table 42. Pfizer Major Business
    Table 43. Pfizer Meningococcal Conjugate Product and Services
    Table 44. Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Pfizer Recent Developments/Updates
    Table 46. Pfizer Competitive Strengths & Weaknesses
    Table 47. Glaxo Smith Kline Basic Information, Area Served and Competitors
    Table 48. Glaxo Smith Kline Major Business
    Table 49. Glaxo Smith Kline Meningococcal Conjugate Product and Services
    Table 50. Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Glaxo Smith Kline Recent Developments/Updates
    Table 52. Glaxo Smith Kline Competitive Strengths & Weaknesses
    Table 53. Hualan Biological Engineering Basic Information, Area Served and Competitors
    Table 54. Hualan Biological Engineering Major Business
    Table 55. Hualan Biological Engineering Meningococcal Conjugate Product and Services
    Table 56. Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Hualan Biological Engineering Recent Developments/Updates
    Table 58. Hualan Biological Engineering Competitive Strengths & Weaknesses
    Table 59. JN International Medical Corporation Basic Information, Area Served and Competitors
    Table 60. JN International Medical Corporation Major Business
    Table 61. JN International Medical Corporation Meningococcal Conjugate Product and Services
    Table 62. JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. JN International Medical Corporation Recent Developments/Updates
    Table 64. JN International Medical Corporation Competitive Strengths & Weaknesses
    Table 65. Baxter International Basic Information, Area Served and Competitors
    Table 66. Baxter International Major Business
    Table 67. Baxter International Meningococcal Conjugate Product and Services
    Table 68. Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Baxter International Recent Developments/Updates
    Table 70. Baxter International Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Meningococcal Conjugate Product and Services
    Table 74. Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. Merck Competitive Strengths & Weaknesses
    Table 77. Serum Institute of India Basic Information, Area Served and Competitors
    Table 78. Serum Institute of India Major Business
    Table 79. Serum Institute of India Meningococcal Conjugate Product and Services
    Table 80. Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Serum Institute of India Recent Developments/Updates
    Table 82. Serum Institute of India Competitive Strengths & Weaknesses
    Table 83. Biomed Basic Information, Area Served and Competitors
    Table 84. Biomed Major Business
    Table 85. Biomed Meningococcal Conjugate Product and Services
    Table 86. Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Biomed Recent Developments/Updates
    Table 88. Novartis Basic Information, Area Served and Competitors
    Table 89. Novartis Major Business
    Table 90. Novartis Meningococcal Conjugate Product and Services
    Table 91. Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Meningococcal Conjugate Upstream (Raw Materials)
    Table 93. Meningococcal Conjugate Typical Customers
List of Figure
    Figure 1. Meningococcal Conjugate Picture
    Figure 2. World Meningococcal Conjugate Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Meningococcal Conjugate Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Meningococcal Conjugate Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Meningococcal Conjugate Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Meningococcal Conjugate Revenue (2018-2029) & (USD Million)
    Figure 13. Meningococcal Conjugate Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Meningococcal Conjugate Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Meningococcal Conjugate Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Meningococcal Conjugate by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Meningococcal Conjugate Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Meningococcal Conjugate Markets in 2022
    Figure 27. United States VS China: Meningococcal Conjugate Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Meningococcal Conjugate Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Meningococcal Conjugate Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Meningococcal Conjugate Market Size Market Share by Type in 2022
    Figure 31. Menactra
    Figure 32. Menveo
    Figure 33. NeisVac-C
    Figure 34. Nimenrix
    Figure 35. Others
    Figure 36. World Meningococcal Conjugate Market Size Market Share by Type (2018-2029)
    Figure 37. World Meningococcal Conjugate Market Size by End User, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Meningococcal Conjugate Market Size Market Share by End User in 2022
    Figure 39. Children
    Figure 40. Preteens or Teens
    Figure 41. Adults
    Figure 42. Meningococcal Conjugate Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source